What tests might be needed before treatment?
Most people with genitourinary syndrome of menopause (GSM) can start care based on history and examination alone. Tests are used selectively to rule out infections, check pH, assess skin conditions, or investigate red flags like post-menopausal bleeding. Swabs, urine tests, and—rarely—biopsy may be suggested depending on symptoms. Your clinician will explain what each test is for and how results guide a step-wise plan. Educational only. Results vary. Not a cure.
Detailed Medical Explanation
Why testing is sometimes needed. GSM is usually a clinical diagnosis: your story (dryness, burning, stinging with urine on delicate skin, dyspareunia, urinary urgency/frequency) plus a gentle examination often provides enough clarity to begin treatment. Tests are added to confirm or exclude specific alternatives (thrush, bacterial vaginosis, urinary tract infection), to assess severity (vaginal pH), or to evaluate skin conditions (e.g., lichen sclerosus) that can mimic or compound dryness. Investigations also help when symptoms persist or red flags appear (e.g., post-menopausal bleeding), ensuring the plan is safe and targeted.
Typical tests and when they’re suggested. 1) Vaginal pH testing: a simple strip placed in the vagina; pH is often >5 in GSM due to reduced lactobacilli and glycogen. 2) High-vaginal swab or microscopy/culture: recommended if there is unusual discharge, odour, or intense itching to check for thrush or bacterial vaginosis. 3) Urine dip/culture: if dysuria, urgency/frequency or recurrent UTIs are present, to confirm infection and guide antibiotics only when needed. 4) Dermatology assessment: if white plaques, fissures, or architectural changes suggest a dermatosis; occasionally a small skin biopsy confirms lichen sclerosus or rules out other causes of fragility. 5) Cervical screening: not a GSM test, but staying up-to-date avoids missed issues that can also cause spotting. 6) Pelvic ultrasound or hysteroscopy: reserved for specific red flags (e.g., post-menopausal bleeding) rather than routine GSM.
Tests that are usually not required. Routine blood tests are seldom needed purely for GSM. Hormone levels (oestrogen, FSH) do not diagnose GSM in everyday practice; symptoms and examination guide care. Swabs “just in case” aren’t helpful if you have classic dryness without discharge or odour—false positives can lead to unnecessary medicines and extra irritation.
How results guide your plan. If swabs are negative and pH is high, the pattern points strongly to GSM, so non-hormonal foundations (regular vaginal moisturiser, the right personal lubricant, gentle vulval care) are prioritised and local oestrogen or vaginal DHEA is often added when symptoms affect quality of life. If cultures confirm thrush or BV, targeted treatment is given first; persistent soreness after infection clears often benefits from GSM-centred care to restore comfort and pH. For urinary symptoms, a positive culture is treated; if UTIs recur and GSM is present, local oestrogen can reduce episodes over time.
What to expect in clinic. Your clinician will discuss which, if any, tests are appropriate for you based on symptoms and examination. You can review how care is delivered and sequenced in our clinic here: how treatment steps are sequenced, and common questions are covered in our treatment FAQs. Not everyone needs investigations before starting moisturisers, lubricants and local therapy; decisions are shared, balancing comfort, clarity and safety.
Trusted resources for further reading. The NHS explains vaginal dryness and when to seek help. The UK guideline from NICE (NG23) sets out step-wise management of menopause-related symptoms, including GSM. Prescribers and informed patients can find product cautions and dosing in the British National Formulary (BNF). Randomised evidence summaries for local oestrogen are available in the Cochrane Library. For skin conditions that can require biopsy, the British Association of Dermatologists explains key features of lichen sclerosus.
Clinical Context
Who may not need tests before treatment? Many with classic GSM—dryness, friction pain, stinging at the entrance, little discharge—can start with moisturisers/lubricants and consider local oestrogen without swabs or bloods. Who might need tests? Those with strong odour, clumpy or grey discharge, fever, pelvic pain, visible ulcers or white plaques, recurrent UTIs, or post-menopausal bleeding. A urine culture helps if bladder symptoms suggest infection; vaginal swabs help when discharge changes; a small biopsy may be considered for suspected dermatoses.
Who should seek prompt review? Anyone with post-menopausal bleeding, visible blood in urine, severe/worsening pain, or systemic illness. People with a history of hormone-sensitive cancer should discuss local oestrogen or vaginal DHEA with oncology and menopause teams. Alternatives for those avoiding hormones include scheduled non-hormonal moisturisers (often with hyaluronic acid), tailored lubricants, pelvic floor physiotherapy, and psychosexual support. Plan a 6–12-week follow-up to review response and adjust to the lowest effective maintenance once comfortable.
Evidence-Based Approaches
Guidelines endorse clinical diagnosis supported by targeted tests, not a blanket panel. The NICE Menopause Guideline (NG23) recommends offering information on moisturisers/lubricants and considering low-dose local vaginal oestrogen for GSM when symptoms affect quality of life; this may be used with or without systemic HRT. The BNF provides UK product details and cautions for local therapies and medicines used for co-existing conditions (e.g., bladder treatments).
Cochrane reviews find that low-dose local oestrogens improve dryness, soreness, dyspareunia and vaginal pH versus placebo, with broadly similar efficacy across creams, pessaries/tablets and rings, and low systemic absorption at licensed doses; see the Cochrane Library. NHS information on vaginal dryness offers practical self-care and red-flag advice. For differentiating dermatoses that may require biopsy, see the British Association of Dermatologists on lichen sclerosus. Together, these sources support a pragmatic approach: start with proven basics, test when the pattern suggests infection or skin disease, and escalate care step-wise according to response.